Home / Stocks / Wockhardt Limited
WOCKPHARMA

Wockhardt Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹2,187.0

Change

+160.4 (7.91%)

Open

₹2,026.0

Prev. Close

₹2,026.6

Day High

₹2,197.0

Day Low

₹1,992.6

Volume Analysis

Traded

2,447,693

Delivered

769,419

Delivery %

31.43%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (20.0%)

Weaknesses (2)

  • •Low return on equity (6.11%)
  • •Promoter holding is falling

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹2,462.86 ₹2,329.93 ₹2,258.46 ₹2,125.53 ₹2,054.06 ₹1,921.13 ₹1,849.66
Fibonacci ₹2,329.93 ₹2,251.85 ₹2,203.61 ₹2,125.53 ₹2,047.45 ₹1,999.21 ₹1,921.13
Camarilla ₹2,243.21 ₹2,224.47 ₹2,205.74 ₹2,125.53 ₹2,168.26 ₹2,149.53 ₹2,130.79

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+53.7%

1 Week

+6.48%

1 Month

+16.5%

3 Months

+15.94%

6 Months

+38.82%

1 Year

+65.04%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹305.79

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

7.1%

Net margin 10.8% × asset turnover 0.38x × equity multiplier 1.73x

Company Overview

Sector

Healthcare

Market Cap

₹32,944 Cr

P/E (TTM)

82.4

ROE

6.11%

Book Value

₹317.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Wockhardt Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 51/100. The strongest factor is Financial Strength (92/100), while Valuation (10/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (20.0%); low return on equity (6.11%); promoter holding is falling. FII holding has been rising.

TopFund Score — Fundamentals Quality

51/100 — Average

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

92

Growth

21

Valuation

10

Cash Flow

38

Corporate Governance

43

Momentum

70

Institutional Ownership

62

Business Quality

57

Risk & Volatility

60

Liquidity

61

From Screener.in

  • −Stock is trading at 6.39 times its book value
  • −The company has delivered a poor sales growth of 4.49% over past five years.
  • −Company has a low return on equity of -1.43% over last 3 years.
  • −Promoter holding has decreased over last 3 years: -5.81%

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Independent Director Vinesh Kumar Jairath completed second five-year term, ceased on November 9, 2026.

CRISIL report for quarter ended September 30, 2026: no deviation; ₹1,000 crore QIP, ₹893.32 crore utilized.

Wockhardt designated Sumit Garg, Chief Digital & Information Officer, as Senior Management Personnel on 2 November 2026.

Wockhardt reported Q2 FY27 PAT of Rs 73 crore; revenue rose 24% to Rs 969 crore.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 753 701 700 739 809 721 743 738 782 888 965 929 969
Expenses + 681 664 759 648 699 593 679 666 604 711 740 737 796
Operating Profit 72 37 -59 91 110 128 64 72 178 177 225 192 173
OPM % 10.0% 5.0% -8.0% 12.0% 14.0% 18.0% 9.0% 10.0% 23.0% 20.0% 23.0% 21.0% 18.0%
Other Income + 24 8 10 30 9 8 15 -77 21 15 67 31 11
Interest 76 77 73 73 73 60 48 48 55 60 50 52 56
Depreciation 55 55 58 54 55 55 53 56 53 65 53 55 55
Profit before tax -35 -87 -180 -6 -9 21 -22 -109 91 67 189 116 73
Tax % 109.0% -1.0% -2.0% 167.0% 78.0% 5.0% 105.0% -1.0% 10.0% 9.0% 13.0% 8.0% 0.0%
Net Profit + -73 -86 -177 -16 -16 20 -45 -108 82 61 164 107 73
EPS in Rs -5 -6 -11 -1 -1 1 -2 -6 5 4 10 7 5
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 11 0 3 15 7 3 6 0 -3 23 30 26 24

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 4,482 4,453 4,015 3,937 3,566 2,844 2,708 3,230 2,651 2,798 3,012 3,373 3,751
Expenses + 3,772 3,959 4,002 3,935 3,604 2,725 2,771 2,932 2,549 2,707 2,619 2,721 2,984
Operating Profit 709 494 13 2 -38 119 -63 298 102 91 393 652 767
OPM % 16.0% 11.0% 0.3% 0.1% -1.1% 4.2% -2.3% 9.0% 3.9% 3.2% 13.0% 19.0% 20.0%
Other Income + 67 66 114 -238 116 133 975 -163 -173 17 62 26 124
Interest 55 129 225 255 265 276 249 299 302 305 254 213 218
Depreciation 145 142 149 150 164 224 246 247 251 223 217 227 228
Profit before tax 575 289 -247 -641 -351 -247 417 -411 -624 -420 -16 238 445
Tax % 28.0% 13.0% -9.0% 4.0% -38.0% -82.0% -65.0% -32.0% 0.0% 12.0% 256.0% 16.0% —
Net Profit + 413 252 -226 -667 -217 -43 688 -279 -621 -472 -57 199 405
EPS in Rs 34 21 -16 -51 -16 -6 57 -17 -39 -30 -3 13 25
Dividend Payout % 54.0% 0.0% -56.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth -7 -1 -10 -2 -9 -20 -5 19 -18 6 8 12 26

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 3,362 3,720 3,281 2,797 2,619 2,616 3,321 3,777 3,282 3,282 4,272 4,859 5,077
Borrowings + 2,309 2,677 4,160 3,748 3,375 3,582 2,674 2,198 2,184 2,356 2,021 2,233 2,238
Other Liabilities + 1,213 1,622 1,486 1,528 1,764 1,894 1,696 2,168 2,113 1,899 1,726 1,405 1,506
Total Liabilities 6,939 8,074 8,982 8,128 7,813 8,148 7,746 8,215 7,651 7,614 8,100 8,578 8,902
Fixed Assets + 2,123 2,809 2,773 2,888 3,058 3,502 3,343 3,462 3,042 2,881 2,736 2,791 4,655
CWIP 1,007 1,036 1,244 1,433 1,445 1,585 1,379 1,342 1,539 1,722 2,033 2,379 676
Investments 341 0 563 214 0 0 0 0 0 0 422 412 117
Other Assets + 3,468 4,228 4,403 3,593 3,309 3,060 3,024 3,411 3,070 3,011 2,909 2,996 3,454
Total Assets 6,939 8,074 8,982 8,128 7,813 8,148 7,746 8,215 7,651 7,614 8,100 8,578 8,902
Equity Capital 55 55 55 55 55 55 55 72 72 77 81 81 81

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 355 -42 -269 68 183 649 -287 413 153 219 -22 390
Cash from Investing Activity + -222 -105 -684 635 93 -147 1,471 -204 -118 -138 -780 -231
Cash from Financing Activity + -76 193 1,254 -769 -776 -680 -1,171 -71 -315 334 409 -54
Net Cash Flow 57 46 301 -66 -500 -178 13 138 -280 415 -393 105
Free Cash Flow -76 -105 -678 -238 127 486 -452 202 23 69 -377 76
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 73 -8 -1,887 4,697 -583 560 270 171 161 274 -13 63

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 54.93% → 49.33%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 40.59% 38.06% 37.62% 36.21% 34.54% 33.5% 32.6% 32.79% 33.36% 32.84% 34.44% 34.64%
Promoters 54.93% 51.6% 51.99% 51.99% 49.09% 49.09% 49.09% 49.09% 49.09% 49.09% 49.09% 49.33%
Government 0.0% 0.01% 0.01% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.04% 0.02% 0.01%
FII 4.18% 5.49% 5.94% 6.7% 6.54% 6.82% 7.29% 7.1% 7.0% 7.09% 7.23% 7.02%
DII 0.3% 4.82% 4.45% 5.08% 9.82% 10.58% 11.0% 11.0% 10.55% 10.96% 9.24% 9.0%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Wockhardt Limited (this stock) 32,944 82.4 6.39 6.11%
Piramal Pharma Limited 32,557 — 4.0 -3.83%
Dr. Lal Path Labs Ltd. 33,582 55.5 12.2 22.3%
Acutaas Chemicals Limited 32,281 73.5 17.37 24.0%
Krishna Inst Of Med Sci L 31,903 157.0 8.11 11.3%
Narayana Hrudayalaya Ltd. 37,889 41.8 7.57 20.5%
Rubicon Research Limited 27,764 85.5 19.59 27.0%

Which Mutual Funds Hold Wockhardt Limited?

Frequently Asked Questions about Wockhardt Limited

Community Sentiment

What are other investors saying about Wockhardt Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.